Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Brucker

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
International Neurourology Journal|October 15, 2019
Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson DiseaseGregory Vurture, Benoit Peyronnet, Jose-Alberto Palma, et al.
BJU International|November 6, 2009
Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapyMatthew J Resnick, Daniel J Canter, Thomas J Guzzo, et al.
Toxins|October 25, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic IndicationGrace Forde, Benjamin M Brucker, Kimberly Becker Ifantides, et al.
Reviews in Urology|November 27, 2019
Nocturia in Patients With Multiple SclerosisBenoit Peyronnet, Lauren B Krupp, W Stuart Reynolds, et al.
Parkinsonism & Related Disorders|July 25, 2018
Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohortBenoit Peyronnet, Gregory Vurture, Jose-Alberto Palma, et al.
Neurourology and Urodynamics|November 30, 2023
Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin-A injection for overactive bladder: A multi-institutional collaboration from the SUFU Research Network (SURN)Katherine Shapiro, Jennifer Anger, Anne P Cameron, et al.
Neurourology and Urodynamics|April 14, 2025
Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive BladderAnjali Kapur, Monica Van Til, Stephanie Daignault-Newton, et al.
Neurourology and Urodynamics|October 10, 2018
AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic reviewBenoit Peyronnet, Eabhann O'Connor, Rose Khavari, et al.
Neurourology and Urodynamics|January 12, 2022
Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research networkWilliam Stuart Reynolds, Anne M Suskind, Jennifer T Anger, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
International Neurourology Journal|October 15, 2019
Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson DiseaseGregory Vurture, Benoit Peyronnet, Jose-Alberto Palma, et al.
BJU International|November 6, 2009
Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapyMatthew J Resnick, Daniel J Canter, Thomas J Guzzo, et al.
Toxins|October 25, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic IndicationGrace Forde, Benjamin M Brucker, Kimberly Becker Ifantides, et al.
Reviews in Urology|November 27, 2019
Nocturia in Patients With Multiple SclerosisBenoit Peyronnet, Lauren B Krupp, W Stuart Reynolds, et al.
Parkinsonism & Related Disorders|July 25, 2018
Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohortBenoit Peyronnet, Gregory Vurture, Jose-Alberto Palma, et al.
Neurourology and Urodynamics|November 30, 2023
Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin-A injection for overactive bladder: A multi-institutional collaboration from the SUFU Research Network (SURN)Katherine Shapiro, Jennifer Anger, Anne P Cameron, et al.
Neurourology and Urodynamics|April 14, 2025
Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive BladderAnjali Kapur, Monica Van Til, Stephanie Daignault-Newton, et al.
Neurourology and Urodynamics|October 10, 2018
AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic reviewBenoit Peyronnet, Eabhann O'Connor, Rose Khavari, et al.
Neurourology and Urodynamics|January 12, 2022
Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research networkWilliam Stuart Reynolds, Anne M Suskind, Jennifer T Anger, et al.
Pageof 9